Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Malaghan Institute Of Medical Research

Clinical trials sponsored by Malaghan Institute Of Medical Research, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New immune therapy shows promise for Tough-to-Treat lymphoma Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New immune therapy shows promise for Tough-to-Treat lymphoma

Disease control Recruiting now

This phase 2 trial is testing a new CAR T-cell therapy called WZTL-002 for people with large B-cell lymphoma that has come back or not responded to standard treatment. The therapy uses a patient's own immune cells, modified to target and kill cancer cells. The study will measure …

Phase 2 • Sponsor: Malaghan Institute of Medical Research • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC